Tagged Articles

risk of death 14 articles

Study links COPD inhaler to 52 percent increased risk of death

A mist inhaler with the drug Spiriva has been shown to increase the risk of death by 52 percent in people with chronic obstructive pulmonary disease (COPD), according to a new review. The mist inhaler, called Respimat, which contains the drug Spiriva (tiotropium), is approved in 55 countries, but not yet in the United States. Spirivia is approved in the U.S. for COPD in a powdered form delivered with a “Handihaler,” which was  not included in the review. The new study, led by Dr. Sonal Signh, an assistant professor of general internal medicine at the Johns Hopkins University School of Medicine in Baltimore, ... Read More

Study: 1 in 5 patients who receive heart defibrillators do not need them

One in five heart patients who receive implanted defibrillators should not have received one and face a greater risk of health complications and death following implantation, according to a study published this week in the Journal of the American Medical Association. Researchers uncovered this shocking new data by analyzing the medical records of 110,000 people who received an implantable cardioverter-defibrillator, or ICD, between January 2006 and June 2009. The data showed that 22.5 percent of the procedures did not meet current guidelines, and patients who don’t meet the medical criteria for an implant but got one anyway were at about ... Read More

Whitco stadium lights may fall, pose risk of serious injury or death

The U.S. Consumer Product Safety Commission (CPSC) is reminding the public, school officials, facilities managers, and municipal and public safety officials with Whitco Company LP stadium light poles to have them inspected by a qualified engineer immediately because these 70- to 135-foot, 1- to 4-ton poles can fracture or crack and fall over, posing a risk of serious injury or death to patrons and bystanders from being hit or crushed. The poles could put hundreds of people at risk if they fall toward a crowded stadium or onto a building. CSPC first alerted consumers about the potential risk last August. ... Read More

Blood pressure drug may increase death risk in type 2 diabetics

The Food and Drug Administration (FDA) is reviewing data from two clinical trials that suggest the blood pressure medication Benicar (olmesartan) may increase the risk of death from cardiovascular causes in patients with type 2 diabetes, according to an FDA safety announcement. The agency is continuing to review the data from two studies, ROADMAP and ORIENT, and is considering additional ways to asses the cardiovascular effects of Benicar. Both ROADMAP and ORIENT are long-term clinical trials. In both studies, patients with type 2 diabetes were either given Benicar or a placebo to determine if Benicar would slow the progression of ... Read More